Featuring ReliantHeart’s Chief Medical Officer Dr. Billy Cohn: Johnson & Johnson to build new medical device facility in Houston Joe Martin Houston Business Journal October 18, 2016. Johnson & Johnson (NYSE: JNJ) plans to build a first-of-its-kind medical device incubator in Houston, and it will be led by a prominent Bayou City cardiovascular surgeon. Dr. Billy Cohn has been named… Read more »
August 17, 2016. By Madeleine Armstrong. EP Vantage The heart pump space has been an active area for acquisitions recently, with the two main companies, Thoratec and HeartWare, both being bought in the last year or so. One of the few smaller groups left, ReliantHeart, has just CE marked its flagship aVAD device, which could… Read more »
Posted in Implantable Devices by Marie Thibault on August 2, 2016 ReliantHeart’s next-generation aVAD™ left ventricular assist device has just earned CE Mark approval and implants are set to begin in September. ReliantHeart’s new left ventricular assist device (LVAD), the aVAD™, has been approved for commercial implants in Europe. On Tuesday, the company received CE… Read more »
Posted in Implantable Devices by mthibault on July 15, 2016 Yes, that fully-implantable wireless LVAD really is in the works. While Thoratec and HeartWare are being absorbed into large medtech companies, ReliantHeart’s CEO says his standalone LVAD company is debuting the most exciting features in the field. ReliantHeart’s aVAD is a small, intraventricular device with… Read more »
Physicians at the University of Chicago Medicine implanted a HeartAssist5 left ventricular assist device, a tiny electric pump that boosts the circulation when the heart’s left ventricle can no longer function.
Houston-based ReliantHeart Inc. has closed on the first phase of what could be a $16 million capital raise, CEO Rodger Ford told the Houston Business Journal.
ReliantHeart, a Houston, TX-based company that makes the HeartAssist5 (HA5) LVAD, has announced a partnership with Dualis MedTech GmbH to develop a fully-implantable LVAD.
When Fiona Coote had a heart failure in 1984, a transplant was the only option. Three decades later, one of the surgeons who operated on the teenager believes heart transplants will soon be a thing of the past.
ReliantHeart touts study data finding that its HeartAssist5 left ventricular assist device poses a lower risk of blood clots and damage compared with Thoratec’s HeartMate II.
Head to Head thrombogenic performance comparative study of the two VADs: Thoratec HeartMate II and the ReliantHeart – HeartAssist5®, demonstrates that Clotting and Thrombus formation patterns observed in the HeartMate II are absent in the HeartAssist5®